Biotech | November 12, 2021
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
Evidence also shows better immune response to virus among users of spray
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
It is the world’s first DNA-based Covid vaccine
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Subscribe To Our Newsletter & Stay Updated
